Jazz Pharmaceuticals (JAZZ) EBITDA Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded EBITDA Margin of 35.36% in Q2 2026, up 84.36 percentage points from -49.00% a year earlier but down 13.10 percentage points from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) EBITDA Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Jazz Pharmaceuticals' EBITDA Margin came in at 35.09% as of Jun 30, 2026, up 25.77 percentage points year-over-year; for FY2025, it was 6.23%, down 27.60 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -21.53 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 33.83% in FY2024 (+2.09 pp), 31.75% in FY2023 (+16.34 pp), 15.41% in FY2022 (-7.95 pp) and 23.36% in FY2021 (-4.41 pp).
- Quarterly EBITDA Margin has ranged from -49.00% in Q2 2025 to 48.46% in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +2.23 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 84.36 percentage points in Q2 2026, against a drop of 84.40 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 48.46% (Q1 2026), 36.20% (Q4 2025) and 20.94% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn | 35.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.36% |
| Mar 31, 2026 | 48.46% |
| Dec 31, 2025 | 36.20% |
| Sep 30, 2025 | 20.94% |
| Jun 30, 2025 | -49.00% |
| Mar 31, 2025 | 12.13% |
| Dec 31, 2024 | 33.01% |
| Sep 30, 2024 | 40.33% |
| Jun 30, 2024 | 35.40% |
| Mar 31, 2024 | 25.45% |
| Dec 31, 2023 | 27.84% |
| Sep 30, 2023 | 34.45% |
| Jun 30, 2023 | 33.14% |
| Mar 31, 2023 | 31.74% |
| Dec 31, 2022 | -12.21% |
| Sep 30, 2022 | 18.45% |
| Jun 30, 2022 | 25.91% |
| Mar 31, 2022 | 32.84% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 23.38% |
API Access
Jazz Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();